1.Potentized homeopathic drug Arsenicum Album 30C positively modulates protein biomarkers and gene expressions in Saccharomyces cerevisae exposed to arsenate.
Das, Durba ; De, Arnab ; Dutta, Suman ; Biswas, Raktim ; Boujedaini, Naoual ; Khuda-Bukhsh, Anisur Rahman
Journal of Integrative Medicine 2011;9(7):752-60
This study examines if homeopathic drug Arsenicum Album 30C (Ars Alb 30C) can elicit ameliorative responses in yeast (Saccharomyces cerevisiae) exposed to arsenate.
2.Analysis of the capability of ultra-highly diluted glucose to increase glucose uptake in arsenite-stressed bacteria Escherichia coli.
Khuda-Bukhsh, Anisur Rahman ; De, Arnab ; Das, Durba ; Dutta, Suman ; Boujedaini, Naoual
Journal of Integrative Medicine 2011;9(8):901-12
Whether ultra-highly diluted homeopathic remedies can affect living systems is questionable. Therefore, this study sees value in the analysis of whether homeopathically diluted glucose 30C has any effect on Escherichia coli exposed to arsenite stress.
3.Potentized homeopathic drug Arsenicum Album 30C inhibits intracellular reactive oxygen species generation and up-regulates expression of arsenic resistance gene in arsenine-exposed bacteria Escherichia coli.
De, Arnab ; Das, Durba ; Dutta, Suman ; Chakraborty, Debrup ; Boujedaini, Naoual ; Khuda-Bukhsh, Anisur Rahman
Journal of Integrative Medicine 2012;10(2):210-27
To examine if potentized homeopathic drug Arsenicum Album 30C (Ars Alb 30C) can reduce sodium arsenite-induced toxicity in Escherichia coli.
4.Hyperhomocysteinemia, a Biochemical Tool for Differentiating Ischemic and Nonischemic Central Retinal Vein Occlusion during the Early Acute Phase.
Kapil Deb LAHIRI ; Somnath MUKHERJEE ; Sambuddha GHOSH ; Suman MUKHERJEE ; Jayanta DUTTA ; Himadri DATTA ; Harendra Nath DAS
Korean Journal of Ophthalmology 2015;29(2):86-91
PURPOSE: The purpose of the study was to differentiate ischemic central retinal vein occlusion (CRVO) from nonischemic CRVO during the early acute phase using plasma homocysteine as a biochemical marker. METHODS: Fasting plasma homocysteine, serum vitamin B12, and folate levels were measured in 108 consecutive unilateral elderly adult (age >50 years) ischemic CRVO patients in the absence of local and systemic disease and compared with a total of 144 age and sex matched nonischemic CRVO patients and 120 age and sex matched healthy control subjects. RESULTS: Homocysteine level was significantly increased in the patients with ischemic CRVO in comparison with nonischemic CRVO patients (p = 0.009) and also in comparison with control subjects (p < 0.001). Analysis also showed that hyperhomocysteinemia was associated with increased incidence of ischemic CRVO (odds ratio, 18) than that for nonischemic CRVO (odds ratio, 4.5). Serum vitamin B12 and folate levels were significantly lower (p < 0.001) in CRVO patients compared to the control but were not significantly different between nonischemic and ischemic CRVO patients (p > 0.1). CONCLUSIONS: Hyperhomocysteinemia can be regarded as useful in differentiating nonischemic and ischemic CRVO during the early acute phase in absence of local and systemic disease in the elderly adult (age >50 years) population.
Acute Disease
;
Aged
;
Biomarkers/*blood
;
Case-Control Studies
;
Diagnosis, Differential
;
Female
;
Follow-Up Studies
;
Humans
;
Hyperhomocysteinemia/blood/*complications/diagnosis
;
Male
;
Middle Aged
;
Prospective Studies
;
Retinal Vein Occlusion/complications/*diagnosis
;
Time Factors
5.Design and fabrication of scaffolds for anatomic bone reconstruction.
Scott J Hollister ; Chia-Ying Lin ; Cheng-Yu Lin ; Rachel D Schek ; Juan M Taboas ; Colleen L Flanagan ; Eiji Saito ; Jessica M Williams ; Suman Das ; Tobias Wirtz ; Paul H Krebsbach
The Medical journal of Malaysia 2004;59 Suppl F():131-2
Result Analysis
Print
Save
E-mail